BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 25528574)

  • 1. Statistical analysis plan for the Erythropoietin in Traumatic Brain Injury trial: a randomised controlled trial of erythropoietin versus placebo in moderate and severe traumatic brain injury.
    Presneill J; Little L; Nichol A; French C; Cooper DJ; Haddad S; Duranteau J; Huet O; Skrifvars M; Arabi Y; Bellomo R; ;
    Trials; 2014 Dec; 15():501. PubMed ID: 25528574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statistical analysis plan for the POLAR-RCT: The Prophylactic hypOthermia trial to Lessen trAumatic bRain injury-Randomised Controlled Trial.
    Presneill J; Gantner D; Nichol A; McArthur C; Forbes A; Kasza J; Trapani T; Murray L; Bernard S; Cameron P; Capellier G; Huet O; Newby L; Rashford S; Rosenfeld JV; Smith T; Stephenson M; Varma D; Vallance S; Walker T; Webb S; James Cooper D;
    Trials; 2018 Apr; 19(1):259. PubMed ID: 29703266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erythropoietin in traumatic brain injury: study protocol for a randomised controlled trial.
    Nichol A; French C; Little L; Presneill J; Cooper DJ; Haddad S; Duranteau J; Huet O; Skrifvars M; Arabi Y; Bellomo R;
    Trials; 2015 Feb; 16():39. PubMed ID: 25884605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erythropoietin in traumatic brain injury (EPO-TBI): a double-blind randomised controlled trial.
    Nichol A; French C; Little L; Haddad S; Presneill J; Arabi Y; Bailey M; Cooper DJ; Duranteau J; Huet O; Mak A; McArthur C; Pettilä V; Skrifvars M; Vallance S; Varma D; Wills J; Bellomo R; ;
    Lancet; 2015 Dec; 386(10012):2499-506. PubMed ID: 26452709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-Effectiveness of Erythropoietin in Traumatic Brain Injury: A Multinational Trial-Based Economic Analysis.
    Knott RJ; Harris A; Higgins A; Nichol A; French C; Little L; Haddad S; Presneill J; Arabi Y; Bailey M; Cooper DJ; Duranteau J; Huet O; Mak A; McArthur C; Pettilä V; Skrifvars MB; Vallance S; Varma D; Wills J; Bellomo R
    J Neurotrauma; 2019 Sep; 36(17):2541-2548. PubMed ID: 30907230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progesterone for acute traumatic brain injury.
    Ma J; Huang S; Qin S; You C; Zeng Y
    Cochrane Database Syst Rev; 2016 Dec; 12(12):CD008409. PubMed ID: 28005271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of dexanabinol in severe traumatic brain injury: results of a phase III randomised, placebo-controlled, clinical trial.
    Maas AI; Murray G; Henney H; Kassem N; Legrand V; Mangelus M; Muizelaar JP; Stocchetti N; Knoller N;
    Lancet Neurol; 2006 Jan; 5(1):38-45. PubMed ID: 16361021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statistical analysis plan for the EuroHYP-1 trial: European multicentre, randomised, phase III clinical trial of the therapeutic hypothermia plus best medical treatment versus best medical treatment alone for acute ischaemic stroke.
    Winkel P; Bath PM; Gluud C; Lindschou J; van der Worp HB; Macleod MR; Szabo I; Durand-Zaleski I; Schwab S;
    Trials; 2017 Nov; 18(1):573. PubMed ID: 29187242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The citicoline brain injury treatment (COBRIT) trial: design and methods.
    Zafonte R; Friedewald WT; Lee SM; Levin B; Diaz-Arrastia R; Ansel B; Eisenberg H; Timmons SD; Temkin N; Novack T; Ricker J; Merchant R; Jallo J
    J Neurotrauma; 2009 Dec; 26(12):2207-16. PubMed ID: 19803786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic hypothermia to reduce intracranial pressure after traumatic brain injury: the Eurotherm3235 RCT.
    Andrews PJ; Sinclair HL; Rodríguez A; Harris B; Rhodes J; Watson H; Murray G
    Health Technol Assess; 2018 Aug; 22(45):1-134. PubMed ID: 30168413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of Ronopterin (VAS203) in Patients with Moderate and Severe Traumatic Brain Injury (NOSTRA phase III trial): study protocol of a confirmatory, placebo-controlled, randomised, double blind, multi-centre study.
    Tegtmeier F; Schinzel R; Beer R; Bulters D; LeFrant JY; Sahuquillo J; Unterberg A; Andrews P; Belli A; Ibanez J; Lagares A; Mokry M; Willschke H; Flüh C; Schmutzhard E;
    Trials; 2020 Jan; 21(1):80. PubMed ID: 31937347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tranexamic acid to reduce head injury death in people with traumatic brain injury: the CRASH-3 international RCT.
    Roberts I; Shakur-Still H; Aeron-Thomas A; Beaumont D; Belli A; Brenner A; Cargill M; Chaudhri R; Douglas N; Frimley L; Gilliam C; Geer A; Jamal Z; Jooma R; Mansukhani R; Miners A; Pott J; Prowse D; Shokunbi T; Williams J
    Health Technol Assess; 2021 Apr; 25(26):1-76. PubMed ID: 33928903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Right median nerve electrical stimulation for acute traumatic coma (the Asia Coma Electrical Stimulation trial): study protocol for a randomised controlled trial.
    Wu X; Zhang C; Feng J; Mao Q; Gao G; Jiang J
    Trials; 2017 Jul; 18(1):311. PubMed ID: 28693604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of recombinant erythropoietin on long-term outcome after moderate-to-severe traumatic brain injury.
    Skrifvars MB; Luethi N; Bailey M; French C; Nichol A; Trapani T; McArthur C; Arabi YM; Bendel S; Cooper DJ; Bellomo R;
    Intensive Care Med; 2023 Jul; 49(7):831-839. PubMed ID: 37405413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk Adjustment In Neurocritical care (RAIN)--prospective validation of risk prediction models for adult patients with acute traumatic brain injury to use to evaluate the optimum location and comparative costs of neurocritical care: a cohort study.
    Harrison DA; Prabhu G; Grieve R; Harvey SE; Sadique MZ; Gomes M; Griggs KA; Walmsley E; Smith M; Yeoman P; Lecky FE; Hutchinson PJ; Menon DK; Rowan KM
    Health Technol Assess; 2013 Jun; 17(23):vii-viii, 1-350. PubMed ID: 23763763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved outcomes from the administration of progesterone for patients with acute severe traumatic brain injury: a randomized controlled trial.
    Xiao G; Wei J; Yan W; Wang W; Lu Z
    Crit Care; 2008; 12(2):R61. PubMed ID: 18447940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delayed administration of erythropoietin reducing hippocampal cell loss, enhancing angiogenesis and neurogenesis, and improving functional outcome following traumatic brain injury in rats: comparison of treatment with single and triple dose.
    Xiong Y; Mahmood A; Meng Y; Zhang Y; Qu C; Schallert T; Chopp M
    J Neurosurg; 2010 Sep; 113(3):598-608. PubMed ID: 19817538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Very early administration of progesterone for acute traumatic brain injury.
    Wright DW; Yeatts SD; Silbergleit R; Palesch YY; Hertzberg VS; Frankel M; Goldstein FC; Caveney AF; Howlett-Smith H; Bengelink EM; Manley GT; Merck LH; Janis LS; Barsan WG;
    N Engl J Med; 2014 Dec; 371(26):2457-66. PubMed ID: 25493974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.